Zimmer Biomet Holdings Inc (ZBH)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 1,035,200 | 1,030,800 | 1,019,700 | 994,300 | 1,066,200 | 707,100 | 665,400 | 588,100 | 343,700 | 305,600 | 302,100 | 278,100 | 455,100 | 804,800 | 883,100 | 487,600 | -234,900 | -182,900 | -251,400 | 111,000 |
| Revenue (ttm) | US$ in thousands | 7,434,500 | 7,373,400 | 7,289,700 | 7,214,600 | 7,171,500 | 7,054,100 | 6,993,800 | 6,933,800 | 6,780,400 | 6,827,800 | 7,061,000 | 7,290,300 | 7,452,200 | 7,716,200 | 7,722,600 | 6,923,200 | 6,840,900 | 6,881,300 | 6,840,200 | 7,596,700 |
| Pretax margin | 13.92% | 13.98% | 13.99% | 13.78% | 14.87% | 10.02% | 9.51% | 8.48% | 5.07% | 4.48% | 4.28% | 3.81% | 6.11% | 10.43% | 11.44% | 7.04% | -3.43% | -2.66% | -3.68% | 1.46% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,035,200K ÷ $7,434,500K
= 13.92%
Zimmer Biomet Holdings Inc's pretax margin has experienced fluctuations over the past several quarters. The pretax margin represents the percentage of each dollar of the company's revenue that results in pretax profit.
Looking at the data provided, the pretax margin was negative in the second and third quarters of 2020, indicating that the company incurred pretax losses during that period. However, the pretax margin started to improve in the first quarter of 2021, turning positive at 7.04%.
Subsequently, the pretax margin continued to show positive growth in the following quarters, reaching a high point of 14.87% in the fourth quarter of 2023. This suggests that Zimmer Biomet Holdings Inc's operational efficiency and cost management improved significantly during this period.
However, there was a slight decline in the pretax margin in the first quarter of 2024, followed by a relatively stable performance in the next few quarters, hovering around 14%. This stability indicates that the company has been able to maintain its profitability levels.
Overall, Zimmer Biomet Holdings Inc's pretax margin has shown a positive trend with occasional fluctuations, demonstrating the company's ability to generate pretax profits and manage costs effectively over the analyzed period.
Peer comparison
Dec 31, 2024